Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04811300 · ClinicalTrials.gov registry record
mCVI® Lighting Conditions Clinical Study
A clinical trial, sponsored by Intelomed.
- Completed
- Registry status
- 9
- Enrollment target
NCT04811300: Completed study, sponsored by Intelomed.
NCT04811300 is a clinical trial that has completed, run by Intelomed. The registered enrollment target is 9 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04811300 has completed, sponsored by Intelomed.
- COMPLETED
- Registry status
- 9 participants
- Enrollment target
Study Summary
This single center prospective clinical study is to verify the algorithm of mCVI® in 4 different lighting conditions to accurately capture pulse rate and respiratory rate in 10 healthy subjects in comparison to commercially-available Masimo pulse oximeter devices. This is a non significant risk device.
Primary Outcome
To demonstrate that in 4 different lighting environments common to home and office/clinical conditions, mCVI® accurately captures pulse rate in comparison to Masimo pulse oximeter devices.
Interventions
- OTHER There is no intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2021-04-09 |
| Est. Completion | 2021-05-15 |
What the finished NCT04811300 record still lists
NCT04811300 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 9 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which There is no intervention is the first listed.
NCT04811300 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04811300 about?
NCT04811300 is a clinical study titled "mCVI® Lighting Conditions Clinical Study". This single center prospective clinical study is to verify the algorithm of mCVI® in 4 different lighting conditions to accurately capture pulse rate and respiratory rate in 10 healthy subjects in comparison to commercially-available Masimo pulse oximeter devices. This is a non significant risk devi...
What is the current status of trial NCT04811300?
This trial is currently completed. The enrollment target is 9 participants. The study started on 2021-04-09. Estimated completion is 2021-05-15.
What interventions are being tested in trial NCT04811300?
The interventions under investigation include: There is no intervention (OTHER).
Who is sponsoring clinical trial NCT04811300?
This trial is sponsored by Intelomed, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI